Grantham, Mayo, Van Otterloo & Co (GMO)
ONEM

Grantham, Mayo, Van Otterloo & Co (GMO)’s 1Life Healthcare ONEM Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-930,595
Closed -$15.6M – 785
2022
Q4 		$15.6M Buy
+930,595
New +$15.7M 0.08% 198

Grantham, Mayo, Van Otterloo & Co (GMO)'s ONEM Position: Q1 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 930,595 shares — an estimated $15.6M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ONEM in Q4 2022 and held it in 1 quarter. The position peaked at $15.6M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 930,595 1Life Healthcare shares in Q1 2023, an estimated $15.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in 1Life Healthcare in Q4 2022 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s 1Life Healthcare position peaked at $15.6M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2023, filed 12 May 2023.